Royce & Associates LP lifted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 12.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 510,261 shares of the company's stock after purchasing an additional 55,545 shares during the period. Royce & Associates LP owned about 0.40% of Surgery Partners worth $16,451,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of SGRY. KBC Group NV grew its holdings in shares of Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after acquiring an additional 576 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company's stock valued at $42,892,000 after purchasing an additional 777,038 shares during the period. WCM Investment Management LLC increased its stake in Surgery Partners by 0.3% in the 3rd quarter. WCM Investment Management LLC now owns 522,084 shares of the company's stock worth $16,665,000 after purchasing an additional 1,819 shares in the last quarter. Versor Investments LP purchased a new position in Surgery Partners in the 3rd quarter worth about $271,000. Finally, State of New Jersey Common Pension Fund D acquired a new stake in Surgery Partners during the 3rd quarter worth about $1,968,000.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. KeyCorp initiated coverage on shares of Surgery Partners in a report on Friday, October 11th. They issued a "sector weight" rating for the company. Cantor Fitzgerald reiterated an "overweight" rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Benchmark restated a "buy" rating and issued a $50.00 target price on shares of Surgery Partners in a report on Monday, August 26th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $49.00 target price on shares of Surgery Partners in a research report on Wednesday, August 7th. Finally, Macquarie dropped their price target on Surgery Partners from $35.00 to $34.00 and set an "outperform" rating on the stock in a research report on Wednesday. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $40.71.
Check Out Our Latest Stock Analysis on SGRY
Surgery Partners Stock Down 7.3 %
Shares of NASDAQ SGRY traded down $1.82 during mid-day trading on Friday, reaching $22.95. The company had a trading volume of 1,227,937 shares, compared to its average volume of 950,542. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.69 and a current ratio of 1.80. Surgery Partners, Inc. has a twelve month low of $22.25 and a twelve month high of $36.92. The stock's 50 day moving average is $30.62 and its 200-day moving average is $28.45. The stock has a market capitalization of $2.92 billion, a PE ratio of -47.81, a price-to-earnings-growth ratio of 18.74 and a beta of 2.76.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The business's revenue for the quarter was up 14.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.15 earnings per share. As a group, equities analysts anticipate that Surgery Partners, Inc. will post 0.83 earnings per share for the current fiscal year.
About Surgery Partners
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.